Press Releases Harbinger Health Begins New Clinical Study in Individuals at High Risk for Cancer December 5, 2023November 13, 2024
Press Releases Harbinger Health Raises $140 Million in Series B Funding to Accelerate Advancement of its Screening Platform for Early-Stage Cancers September 28, 2023August 1, 2024
Press Releases Harbinger Health Expands Industry-Leading Executive Team September 6, 2023May 22, 2024
Press Releases Harbinger Health Announces Data Demonstrating Its Ability to Detect Early-Stage Multi-Cancer at the AACC Annual Scientific Meeting 2023 July 26, 2023May 1, 2024
Press Releases Harbinger Health Appoints May Orfali, M.D. as Chief Medical Officer May 23, 2023May 1, 2024
Press Releases Harbinger Health Announces Results Demonstrating High-Sensitivity of Early Stage Multi-Cancer Detection Platform at ASCO Annual Meeting 2023 April 25, 2023July 1, 2024
Press Releases Harbinger Health Appoints Vincent Lozada as Chief Financial Officer February 13, 2023May 1, 2024
Press Releases Harbinger Health and Sarah Cannon Research Institute Launch Clinical Study to Validate and Advance Development of Harbinger’s Novel Early Cancer Detection Platform June 29, 2022May 1, 2024
Press Releases Flagship Pioneering Launches Harbinger Health to Detect Early Cancer with a Simple, Bio-AI Based Blood Test December 7, 2021May 1, 2024
